These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 18784222

  • 21. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members.
    Mermin J, Lule J, Ekwaru JP, Downing R, Hughes P, Bunnell R, Malamba S, Ransom R, Kaharuza F, Coutinho A, Kigozi A, Quick R.
    AIDS; 2005 Jul 01; 19(10):1035-42. PubMed ID: 15958834
    [Abstract] [Full Text] [Related]

  • 22. Effects of maternal vitamin supplements on malaria in children born to HIV-infected women.
    Villamor E, Msamanga G, Saathoff E, Fataki M, Manji K, Fawzi WW.
    Am J Trop Med Hyg; 2007 Jun 01; 76(6):1066-71. PubMed ID: 17556612
    [Abstract] [Full Text] [Related]

  • 23. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children.
    Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G.
    AIDS; 2007 Oct 01; 21(15):2059-66. PubMed ID: 17885296
    [Abstract] [Full Text] [Related]

  • 24. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D, Mofenson LM.
    J Infect Dis; 2006 Dec 01; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract] [Full Text] [Related]

  • 25. Cotrimoxazole, clinical uses and malaria chemotherapy.
    Fehintola FA.
    Afr J Med Med Sci; 2010 Mar 01; 39(1):63-8. PubMed ID: 20632674
    [Abstract] [Full Text] [Related]

  • 26. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA, Sax PE.
    N Engl J Med; 2001 May 24; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR, Trapnell CB, Slattery JT, Jacobson M, Greenspan DL, Hooton TM, Unadkat JD.
    Clin Pharmacol Ther; 2004 Oct 24; 76(4):313-22. PubMed ID: 15470330
    [Abstract] [Full Text] [Related]

  • 29. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X.
    Med Trop (Mars); 2006 Aug 24; 66(4):343-5. PubMed ID: 16999042
    [Abstract] [Full Text] [Related]

  • 30. [Nodal nocardiosis in 2 patients with HIV infection treated with cotrimoxazole].
    Valencia Ortega ME, Enríquez Crego A, Adrados de Llano M, Moreno Celda V.
    Rev Clin Esp; 1997 Apr 24; 197(4):298-9. PubMed ID: 9254409
    [No Abstract] [Full Text] [Related]

  • 31. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, Bunnell R.
    AIDS Behav; 2006 Jul 24; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [Abstract] [Full Text] [Related]

  • 32. National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya.
    Chakaya JM, Mansoer JR, Scano F, Wambua N, L'Herminez R, Odhiambo J, Mohamed I, Kangangi J, Ombeka V, Akeche G, Adala S, Gitau S, Maina J, Kibias S, Langat B, Abdille N, Wako I, Kimuu P, Sitienei J.
    Int J Tuberc Lung Dis; 2008 Apr 24; 12(4):424-9. PubMed ID: 18371269
    [Abstract] [Full Text] [Related]

  • 33. Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, Kenya.
    Mwachari CW, Shepherd BE, Cleopa O, Odhiambo JA, Cohen CR.
    Int J STD AIDS; 2004 Feb 24; 15(2):120-6. PubMed ID: 15006075
    [Abstract] [Full Text] [Related]

  • 34. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
    Walter J, Mwiya M, Scott N, Kasonde P, Sinkala M, Kankasa C, Kauchali S, Aldrovandi GM, Thea DM, Kuhn L.
    J Infect Dis; 2006 Dec 01; 194(11):1510-8. PubMed ID: 17083035
    [Abstract] [Full Text] [Related]

  • 35. [Escherichia coli meningitis during bacteremia in the Ibrahima-Diop-Mar infectious diseases clinic, Dakar Fann National Hospital Center (Senegal)].
    Seydi M, Soumaré M, Sow AI, Diop BM, Sow PS.
    Med Mal Infect; 2005 Jun 01; 35(6):344-8. PubMed ID: 16039818
    [Abstract] [Full Text] [Related]

  • 36. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    Ottichilo RK, Polyak CS, Guyah B, Singa B, Nyataya J, Yuhas K, John-Stewart G, Waitumbi JN.
    J Infect Dis; 2017 Jan 01; 215(1):88-94. PubMed ID: 28077587
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E, De Silvestri A, Boschi A, Tinelli C.
    AIDS Rev; 2008 Jan 01; 10(4):236-44. PubMed ID: 19092979
    [Abstract] [Full Text] [Related]

  • 40. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM.
    Bull World Health Organ; 2004 Apr 01; 82(4):297-8. PubMed ID: 15259259
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.